Related Experiment Videos
Steroid-induced myopathy in the ICU
Bryan W Polsonetti1, Saju D Joy, Luis F Laos
1Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT 06510, USA. Polsonb2@ynhh.org
The Annals of Pharmacotherapy
|October 26, 2002
Summary
Prolonged corticosteroid use in intensive care can lead to steroid-induced myopathy, causing muscle weakness. Rapid steroid tapering can reverse this condition, improving patient outcomes.
Area of Science:
- Intensive Care Medicine
- Neuromuscular Disorders
- Pharmacology
Background:
- Status asthmaticus often requires high-dose systemic corticosteroids.
- Prolonged corticosteroid administration is associated with potential adverse effects.
Observation:
- A 30-year-old male developed quadriplegia during intensive care for status asthmaticus.
- Electromyography ruled out neuropathy as the cause of paralysis.
- Rapid tapering of systemic steroids led to significant muscle strength recovery.
Findings:
- Steroid-induced myopathy is a rare but serious complication in the intensive care unit.
- High-dose corticosteroids can cause muscle catabolism and weakness through various mechanisms.
- This case highlights the neuromuscular effects of prolonged steroid treatment.
Implications:
- Clinicians must be vigilant for neuromuscular complications in patients receiving long-term steroids.
- Aggressive reduction or elimination of systemic steroids may be necessary to manage myopathy.
- Awareness of steroid-induced myopathy is crucial for optimizing patient care in critical illness.